Chantilly Bio Pharma Private Limited - Due diligence report

A 360° intelligence report on Chantilly Bio Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growt…

2011-07-04 Hyderabad, Telangana Active Unlisted Active Compliant
Share
Connect MCP
CB Chantilly Bio Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Chantilly Bio Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
66/100
Trust Score
Moderate

Chantilly Bio Pharma Private Limited is assessed as Moderate with a Trust Score of 66/100. Chantilly Bio Pharma Private Limited is an active private limited indian non-government company incorporated in 2011, operating in the Research & Development sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 03 Aug 2026 from the latest processed filings. Chantilly Bio Pharma Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
66/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
10/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
45/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
30/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 2 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
NAGAJYOTHI BALUSU 01234567 Director 01/04/2018 6 yrs Approved
KANAKA MALNEEDI DURGA 01234567 Director 01/04/2018 6 yrs Approved
CHERUKURI SUBRAMAN RAO 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Venkor Cpeciality Products Llc
Subsidiaries
-
Group entities
-
Capital events
3 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Venkor Cpeciality Products Llc Holding Company 74.00%

Key managerial personnel: CHERUKURI SUBRAMAN RAO (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 45 · Distress 30
Growth signals & trust indicators
Asset base grew 1.42 - capacity expansion.
Operating for 15+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Outside liabilities up 2.1x in a year.
Negative net worth.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence69/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 4 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment50/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view38/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 11 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
08 Jun 2019
Director appointed
NAGAJYOTHI BALUSU (Director)
23 Jan 2016
Director ceased
VENKATA NAGESWARA RAO CHERUKURI
15 Dec 2015
Securities allotted
3236 Equity Shares - 3.24 Lakh raised
21 Aug 2015
Securities allotted
6422 Equity Shares - 6.42 Lakh raised
20 Aug 2015
Securities allotted
64225 Equity Shares - 6.42 Lakh raised
06 Apr 2015
Director appointed
CHERUKURI SUBRAMAN RAO (Managing Director)
Director ceased
KANAKA MALNEEDI DURGA
04 Jul 2011
Incorporated
Registered with Roc Hyderabad
Director appointed
KANAKA MALNEEDI DURGA (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 24% over the last 1 financial year(s).
Net profit margin moved from 0.86 to 61%.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Madras Institute Of Nephrology Research Private Limited U85110TN2008PTC067559 Chennai, Tamil Nadu, India
A B C Genomics (India) Private Limited U93000UP2007PTC033904 Lucknow, Uttar Pradesh, India
Ksdysa Research And Development India Private Limited U72300UP2016PTC075434 Banda, Uttar Pradesh, India
Technovision Electronics Private Limited U32101DL2004PTC126653 Delhi, Delhi, India
Drishti Academy (India) Private Limited U74920MH2006PTC161098 Mumbai 400 049, Maharashtra, India
Valens Arbor Private Limited U01500MH2012PTC236702 Mumbai, Maharashtra, India
Vaishwik Multibiz Private Limited U74900PN2013PTC147496 Pune, Maharashtra, India
Excellent Bio Research Solutions Private Limited U73100MP2013PTC031190 Jabalpur, Madhya Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Chantilly Bio Pharma Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Chantilly Bio Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 45/100, margin trends, ownership structure and peer set for Chantilly Bio Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 66/100, distress signals and MSME payment-delay disclosures - know whether Chantilly Bio Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Chantilly Bio Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Chantilly Bio Pharma Private Limited an active company?

Chantilly Bio Pharma Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Chantilly Bio Pharma Private Limited financially healthy?

Chantilly Bio Pharma Private Limited has a Financial Health Score of 10/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Chantilly Bio Pharma Private Limited?

Its overall Trust Score is 66/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Chantilly Bio Pharma Private Limited?

The ultimate holding entity is Venkor Cpeciality Products Llc. 3 active director(s) are on record.

Does Chantilly Bio Pharma Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Chantilly Bio Pharma Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Chantilly Bio Pharma Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.